Advertisement
U.S. Markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
30.97+0.19 (+0.62%)
At close: 04:00PM EDT
30.97 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.30B
Enterprise Value 1.92B
Trailing P/E 21.09
Forward P/E 277.78
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)24.76
Price/Book (mrq)4.13
Enterprise Value/Revenue 22.32
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.77
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 353.92
52 Week Low 318.00
50-Day Moving Average 335.68
200-Day Moving Average 341.13

Share Statistics

Avg Vol (3 month) 3934.52k
Avg Vol (10 day) 3988.75k
Shares Outstanding 574.27M
Implied Shares Outstanding 6N/A
Float 872.78M
% Held by Insiders 12.02%
% Held by Institutions 1111.73%
Shares Short (Sep 30, 2024) 412.18M
Short Ratio (Sep 30, 2024) 413.56
Short % of Float (Sep 30, 2024) 419.85%
Short % of Shares Outstanding (Sep 30, 2024) 416.40%
Shares Short (prior month Aug 30, 2024) 412.72M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-75.20%

Management Effectiveness

Return on Assets (ttm)-35.40%
Return on Equity (ttm)-59.72%

Income Statement

Revenue (ttm)86.19M
Revenue Per Share (ttm)1.25
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -318.71M
Net Income Avi to Common (ttm)-301.06M
Diluted EPS (ttm)-4.44
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)383.88M
Total Cash Per Share (mrq)5.17
Total Debt (mrq)7.06M
Total Debt/Equity (mrq)1.27
Current Ratio (mrq)7.91
Book Value Per Share (mrq)7.50

Cash Flow Statement

Operating Cash Flow (ttm)-233.89M
Levered Free Cash Flow (ttm)-135.27M